| Active ingredient (INN) | Gefitinib |
|---|---|
| Brand names | IRESSA gefitinib |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Cipla Australia Pty Ltd, AstraZeneca Pty Ltd, TEVA PHARMACEUTICALS, INC., Mylan Pharmaceuticals Limited +6 more |
| Registrations on file | 14 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| GEFTIRESS gefitinib | 250 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Apo | 250 mg | — | 🇦🇺 AU | — | Active |
| IRESSA gefitinib | 250 mg | — | 🇦🇺 AU | AstraZeneca Pty Ltd | Active |
| Apotex | 250 mg | — | 🇦🇺 AU | — | Active |
| GEFTICIP gefitinib | 250 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Cipla | 250 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Gefitinib | 250mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS, INC. | Active |
| Gefitinib Mylan | — | — | 🌐 EU | Mylan Pharmaceuticals Limited | Withdrawn |
| Apo-Gefitinib | — | tablet | 🇨🇦 CA | APOTEX INC | Active |
| Jamp Gefitinib | — | tablet | 🇨🇦 CA | JAMP PHARMA CORPORATION | Active |
| Sandoz Gefitinib | — | tablet | 🇨🇦 CA | SANDOZ CANADA INCORPORATED | Active |
| Nat-Gefitinib | — | tablet | 🇨🇦 CA | NATCO PHARMA (CANADA) INC | Active |
| Auro-Gefitinib | — | tablet | 🇨🇦 CA | AURO PHARMA INC | Active |
| Eugia-Gefitinib | — | tablet | 🇨🇦 CA | EUGIA PHARMA INC. | Active |